Potential clinical application of antioncogene ribozymes for human lung cancer.
about
Oncogenomics and the development of new cancer therapiesClinical relevance of KRAS in human cancers.Targeting mutated tyrosine kinases in the therapy of myeloid leukaemias.Individualised cancer therapeutics: dream or reality? Therapeutics construction.The clonal evolution and therapeutic approaches of lung cancer.
P2860
Potential clinical application of antioncogene ribozymes for human lung cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Potential clinical application of antioncogene ribozymes for human lung cancer.
@en
type
label
Potential clinical application of antioncogene ribozymes for human lung cancer.
@en
prefLabel
Potential clinical application of antioncogene ribozymes for human lung cancer.
@en
P2093
P356
P1433
P1476
Potential clinical application of antioncogene ribozymes for human lung cancer.
@en
P2093
P304
P356
10.3816/CLC.2001.N.007
P407
P577
2001-02-01T00:00:00Z